The Cost of Insulin

Health Affairs' Jessica Bylander and Chris Fleming dive into the
complex world of insulin pricing and recent efforts to control
its costs for the millions of Americans with diabetes.


Read the Ahead of Print article on Medicare Advantage benchmarks
by Michael Chernew and colleagues.


Related Links:


Sanofi announces insulin price cap after actions by Eli Lilly
and Novo Nordisk (NBC News)

Why is insulin so expensive and difficult to cap? (AP News)

California Picks Generic Drug Company Civica to Produce
Low-Cost Insulin (Kaiser Health News)

Insulin as Preventive Care: Why Not Eliminate Patient Cost
Sharing? (Health Affairs Forefront)



Currently, more than 70 percent of our content is freely
available — and we’d like to keep it that way. With your support,
we can continue to keep our digital publication Forefront and
podcasts free for everyone.